WallStreetZenWallStreetZen

NASDAQ: FENC
Fennec Pharmaceuticals Inc Stock Ownership - Who owns Fennec Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Fennec Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Rosty RaykovDirector2025-08-0510,000$8.09
$80.90kSell
Chris A. RallisDirector2025-07-071,119$8.71
$9.75kSell
Chris A. RallisDirector2025-07-072,127$2.35
$5.00kBuy
Rosty RaykovDirector2025-07-0310,000$8.61
$86.10kSell
Rosty RaykovDirector2025-06-0510,000$7.78
$77.80kSell
Robert AndradeCHIEF FINANCIAL OFFICER2025-05-228,220$5.10
$41.92kBuy
Jeffrey S. HackmanChief Executive Officer2025-05-1913,965$6.99
$97.62kBuy
Rosty RaykovDirector2025-05-1616,667$6.78
$113.00kSell
Jeffrey S. HackmanChief Executive Officer2025-05-161,035$6.75
$6.99kBuy
Rosty RaykovDirector2025-05-0510,000$6.31
$63.10kSell

1 of 3

FENC insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when FENC insiders and whales buy or sell their stock.

FENC Shareholders

What type of owners hold Fennec Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Southpoint Capital Advisors LP738.91%204,077,214$1.74BInsider
Robert W. Butts450.82%124,512,000$1.06BInsider
Southpoint Master Fund LP14.47%3,997,214$34.10MInsider
Spa Essetifin14.46%3,993,694$34.07MInsider
Manchester Management Co LLC7.91%2,184,023$18.63MInsider
Manchester Management Pr LLC7.91%2,184,023$18.63MInsider
William G. Breen4.95%1,367,781$11.67MInsider
Fred H. Mermelstein4.94%1,363,410$11.63MInsider
Blackrock Inc4.44%1,226,437$10.46MInstitution
Vanguard Group Inc3.50%967,092$8.25MInstitution

1 of 3

FENC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
FENC1.04%98.96%Net SellingNet Selling
ALLO42.76%35.22%Net SellingNet Selling
GALT8.70%91.30%Net BuyingNet Buying
LCTX11.34%66.86%Net Buying
AARD22.38%46.82%Net Buying
View Top Biotech Stocks

Fennec Pharmaceuticals Stock Ownership FAQ

Who owns Fennec Pharmaceuticals?

Fennec Pharmaceuticals (NASDAQ: FENC) is owned by 13.14% institutional shareholders, 1,247.07% Fennec Pharmaceuticals insiders, and 0.00% retail investors. Southpoint Capital Advisors LP is the largest individual Fennec Pharmaceuticals shareholder, owning 204.08M shares representing 738.91% of the company. Southpoint Capital Advisors LP's Fennec Pharmaceuticals shares are currently valued at $1.74B.

If you're new to stock investing, here's how to buy Fennec Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.